IHZ

Welcome to the Brand page for “IHZ”, which is offered here for Assays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for use in identifying candidate patient populations for specific therapeutic treatments;assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for scientific, laboratory and research purposes; assay kits comprised of assays and for non-medical purposes for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding;providing scientific research information and analysis relating to biochemicals, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments;.

Its status is currently believed to be active. Its class is unavailable. “IHZ” is believed to be currently owned by “CytomX Therapeutics, Inc.”